The mechanism of allosteric regulation of calcium-independent phospholipase A <sub>2</sub> by ATP and calmodulin binding to the ankyrin domain

Group VIA calcium-independent phospholipase A<sub>2</sub> (iPLA<sub>2</sub>) is a member of the PLA<sub>2</sub> superfamily that exhibits calcium-independent activity in contrast to the other two major types, secreted phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) and cytosolic phospholipase A<sub>2</sub> (cPLA<sub>2</sub>), which both require calcium for their enzymatic activity. Adenosine triphosphate (ATP) has been reported to allosterically activate iPLA<sub>2</sub>, and this has now been verified with a lipidomics-based mixed-micelle assay, but its mechanism of action has been unknown. Hydrogen/deuterium exchange mass spectrometry (HDX-MS) was employed to identify ATP interaction peptide regions located within the ankyrin repeat domain at which ATP interacts. Molecular dynamics simulations revealed the mechanism by which ATP binds to its site and the main residues that interact. Site-directed mutagenesis was used to verify the importance of these residues in the role of ATP in regulating iPLA<sub>2</sub> activity. Importantly, calcium was found to abolish the enhancing regulatory function of ATP and to promote the inhibitory activity by calmodulin. Given previous evidence that calcium does not bind directly to iPLA<sub>2</sub>, its effect appears to be indirect via association with ATP and/or calmodulin. Using HDX-MS, we found that calmodulin interacts with the N terminus peptide region of iPLA<sub>2</sub> consisting of residues 20 to 28. These two regulatory iPLA<sub>2</sub> sites open the road to the development of potential targets for therapeutic intervention.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2024-11-19
DOI
https://doi.org/10.1073/pnas.2411539121
Primary Topic
Neurological diseases and metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The mechanism of allosteric regulation of calcium-independent phospholipase A 2 by ATP and calmodulin binding to the ankyrin domain

Varnavas D. Mouchlis, J. Andrew McCammon, Edward A. Dennis, Jian Cao et al.
Proceedings of the National Academy of Sciences
Neurological diseases and metabolism
article

The mechanism of allosteric regulation of calcium-independent phospholipase A 2 by ATP and calmodulin binding to the ankyrin domain

Varnavas D. Mouchlis, J. Andrew McCammon, Edward A. Dennis, Jian Cao, Daiki Hayashi, Yuan-Hao Hsu, Sheng Li
article en

Abstract

Group VIA calcium-independent phospholipase A<sub>2</sub> (iPLA<sub>2</sub>) is a member of the PLA<sub>2</sub> superfamily that exhibits calcium-independent activity in contrast to the other two major types, secreted phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) and cytosolic phospholipase A<sub>2</sub> (cPLA<sub>2</sub>), which both require calcium for their enzymatic activity. Adenosine triphosphate (ATP) has been reported to allosterically activate iPLA<sub>2</sub>, and this has now been verified with a lipidomics-based mixed-micelle assay, but its mechanism of action has been unknown. Hydrogen/deuterium exchange mass spectrometry (HDX-MS) was employed to identify ATP interaction peptide regions located within the ankyrin repeat domain at which ATP interacts. Molecular dynamics simulations revealed the mechanism by which ATP binds to its site and the main residues that interact. Site-directed mutagenesis was used to verify the importance of these residues in the role of ATP in regulating iPLA<sub>2</sub> activity. Importantly, calcium was found to abolish the enhancing regulatory function of ATP and to promote the inhibitory activity by calmodulin. Given previous evidence that calcium does not bind directly to iPLA<sub>2</sub>, its effect appears to be indirect via association with ATP and/or calmodulin. Using HDX-MS, we found that calmodulin interacts with the N terminus peptide region of iPLA<sub>2</sub> consisting of residues 20 to 28. These two regulatory iPLA<sub>2</sub> sites open the road to the development of potential targets for therapeutic intervention.

Proceedings of the National Academy of SciencesVol. 121(48)
University of California San Diego (US), Kobe University (JP)
National Institute of General Medical Sciences
Good health and well-being
Openalex Percentile: Top 77%
Neurological diseases and metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.